Single herbicides and herbicide premixes for use in winter wheat

The Oklahoma Cooperative Extension Service periodically issues revisions to its publications. The most current edition is made available. For access to an earlier edition, if available for this title, please contact the Oklahoma State University Library Archives by email at [email protected] or by phone at 405-744-6311

3,4-Diaminopyridine Base Effectively Treats the Weakness of Lambert-Eaton Myasthenia

Introduction: 3,4-diaminopyridine has been used to treat Lambert Eaton myasthenia (LEM) for thirty years despite the lack of conclusive evidence of efficacy. Methods: We conducted a randomized double-blind placebo-controlled withdrawal study in LEM patients who had been on stable regimens of 3,4-diaminopyridine base (3,4-DAP) for ≥ 3 months. The primary efficacy endpoint was >30% deterioration in Triple Timed Up-and-Go (3TUG) times during tapered drug withdrawal. The secondary endpoint was self-assessment of LEM–related weakness (W-SAS). Results: 32 participants were randomized to continuous 3,4-DAP or placebo. None of the 14 receiving continuous 3,4-DAP had >30% deterioration in 3TUG time vs 72% of the 18 who tapered to placebo (p<0.0001). W-SAS similarly demonstrated an advantage for continuous treatment over placebo (p<0.0001). Need for rescue and adverse events were more common in the placebo group. Discussion: This trial provides significant evidence of efficacy of 3,4-DAP in the maintenance of strength in LEM

High-Input Management Systems Effect on Soybean Seed Yield, Yield Components, and Economic Break-Even Probabilities

Elevated soybean [Glycine max (L.) Merr.] prices have spurred interest in maximizing soybean seed yield and has led growers to increase the number of inputs in their production systems. However, little information exists about the effects of high-input management on soybean yield and profitability. The purpose of this study was to investigate the effects of individual inputs, as well as combinations of inputs marketed to protect or increase soybean seed yield, yield components, and economic break-even probabilities. Studies were established in nine states and three soybean growing regions (North, Central, and South) between 2012 and 2014. In each site-year both individual inputs and combination high-input (SOYA) management systems were tested. When averaged between 2012 and 2014, regional results showed no seed yield responses in the South region, but multiple inputs affected seed yield in the North region. In general, the combination SOYA inputs resulted in the greatest yield increases (up to 12%) compared to standard management, but Bayesian economic analysis indicated SOYA had low break-even probabilities. Foliar insecticide had the greatest break-even probabilities across all environments, although insect pressure was generally low across all site-years. Soybean producers in North region are likely to realize a greater response from increased inputs, but producers across all regions should carefully evaluate adding inputs to their soybean management systems and ensure that they continue to follow the principles of integrated pest management

Characterizing Genotype X Management Interactions on Soybean Seed Yield

Increased soybean [Glycine max (L.) Merr.] commodity prices in recent years have generated interest in high-input systems to increase yield. The objective of this study was to evaluate the effects of current, high-yielding cultivars under high- and low-input systems on soybean yield and yield components. Research trials were conducted at 19 locations spanning nine states from 2012 to 2014. At each location, six high-yielding cultivars were grown under three input systems: (i) standard practice (SP, current recommended practices), (ii) high-input treatment consisting of a seed treatment fungicide, insecticide, nematistat, inoculant, and lipo-chitooligosaccharide (LCO); soil-applied N fertilizer; foliar LCO, fertilizer, antioxidant, fungicide and insecticide (SOYA), and (iii) SOYA minus foliar fungicide (SOYA-FF). An individual site-year yield analysis found only 3 of 53 (5.7%) site-years examined had a significant cultivar × input system interaction, suggesting cultivar selection and input system decisions can remain independent. Across all site-years, the SOYA and SOYA-FF treatments yielded 231 (5.5%) and 147 kg ha–1 (3.5%) more than the SP, and input system differences were found among maturity groups. Yield component measurements (seeds m–2, seed mass, early-season and final plant stand, pods plant–1, and seeds pod–1) indicated positive yield responses were due to increased seeds m–2 and seed mass. While both high-input systems increased yield on average, grower return on investment (ROI) would be negative given today’s commodity prices. These results further support the use of integrated pest management principles for making input decisions instead of using prophylactic applications to maximize soybean yield and profitability

3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

INTRODUCTION:3,4-diaminopyridine has been used to treat Lambert-Eaton myasthenia (LEM) for 30 years despite the lack of conclusive evidence of efficacy. METHODS:We conducted a randomized double-blind placebo-controlled withdrawal study in patients with LEM who had been on stable regimens of 3,4-diaminopyridine base (3,4-DAP) for ≥ 3 months. The primary efficacy endpoint was &gt;30% deterioration in triple timed up-and-go (3TUG) times during tapered drug withdrawal. The secondary endpoint was self-assessment of LEM-related weakness (W-SAS). RESULTS:Thirty-two participants were randomized to continuous 3,4-DAP or placebo groups. None of the 14 participants who received continuous 3,4-DAP had &gt; 30% deterioration in 3TUG time versus 72% of the 18 who tapered to placebo (P &lt; 0.0001). W-SAS similarly demonstrated an advantage for continuous treatment over placebo (P &lt; 0.0001). Requirement for rescue and adverse events were more common in the placebo group. DISCUSSION:This trial provides significant evidence of efficacy of 3,4-DAP in the maintenance of strength in LEM. Muscle Nerve 57: 561-568, 2018